Clinical Trial Detail

NCT ID NCT02227940
Title Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Roswell Park Cancer Institute
Indications

Advanced Solid Tumor

pancreatic adenocarcinoma

Therapies

Ceritinib + Gemcitabine + Nab-paclitaxel

Ceritinib + Cisplatin + Gemcitabine

Ceritinib + Gemcitabine

Age Groups: senior adult

Additional content available in CKB BOOST